Physician societies file lawsuit on FTC's Red Flags Rule

The American Medical Association (AMA), American Osteopathic Association (AOA) and the Medical Society of the District of Columbia (MSDC) have filed a suit in federal court seeking to prevent the Federal Trade Commission (FTC) from extending identity theft regulations to physicians.

The complaint, prepared by the Litigation Center of the AMA and State Medical Societies, targets the contentious “red flags rule,” which requires creditors to implement safeguards against identity theft. The medical societies charge that the FTC’s rule exceeds the powers delegated to it by Congress and that its application to physicians is “arbitrary, capricious and contrary to the law.”

“This unjustified federal regulation of medicine treats physician practices like banks, credit card companies and mortgage lenders,” said AMA President-elect Cecil B. Wilson, MD. “The extensive bureaucratic burden of complying with the red flags rule outweighs any benefit to the public.”

“The final red flags rule provided no indication from the FTC that physicians fell within the definition of creditor,” said AOA President Larry A. Wickless, DO. “The FTC’s decision to apply the rule to physicians is both misguided and inconsistent with its regulatory power.”

According to the societies, the suit follows two years of communications to the FTC from the AMA and AOA regarding the unintended consequences of the red flags rule. On Jan. 27, the AMA and AOA joined other groups to petition the FTC to exclude physicians from the red flags rule. The FTC responded on March 25 saying it could not accommodate the request.

The AMA, AOA and MSDC said they “strongly disagree” with the FTC’s view that any physician who does not require payment at the time of providing medical services to patients is required to comply with the red flags rule beginning on June 1.


Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.